FindTrial
Sign In

Evaluating the Effectiveness of a Meibomian Gland Massager in Treating Meibomian Gland Dysfunction

Testing the efficacy of meibomian gland massager in managing meibomian gland dysfunction - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079345
Enrollment
106
Registered
2025-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H028- Other specified disorders of eyelid

Interventions

Intervention1: meibomian gland massager: meibomian gland massage therapy given over a period of 2 weeks for patients diagnosed with meibomian gland dysfunction Control Intervention1: not applicable: n

Sponsors

Dr Konda Harshitha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: above 18 years of age diagnosed with meibomian gland dysfunction

Exclusion criteria

Exclusion criteria: 1.other ocular surface disorders 2.patients with autoimmune conditions, diabetes mellitus, ocular infections 3.patients already on topical immunosuppressants 4.with history of eyelid trauma 5.participants who are not willing to provide informed consent are excluded from the study

Design outcomes

Primary

MeasureTime frame
improvement in meibomian gland functionTimepoint: 2 weeks—

Secondary

MeasureTime frame
symptomatic relief, overall ocular comfortTimepoint: 2 weeks—

Countries

India

Contacts

Public ContactDr Konda Harshitha

Saveetha Medical College and Hospital

drskpsaveetha@gmail.com9443217430

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026